Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD
19.00
+0.81 (4.45%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services) | 7.05B | 6.66B | - | 4.57B | 3.24B | | | | | |
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services) Growth | 5.81% | - | - | 41.09% | - | | | | | |
Chemical and formulation process development and manufacturing services | 2.99B | 2.71B | 2.41B | 1.75B | 1.22B | | | | | |
Chemical and formulation process development and manufacturing services Growth | 10.24% | 12.64% | 37.83% | 42.90% | 35.54% | | | | | |
Clinical Research Services | 1.83B | 1.74B | 1.39B | 956.36M | 629.35M | | | | | |
Clinical Research Services Growth | 5.12% | 24.66% | 45.72% | 51.96% | 37.94% | | | | | |
Macromolecule and Cell and Gene Therapy Services | 407.52M | 424.94M | 351.03M | 150.97M | 26.65M | | | | | |
Macromolecule and Cell and Gene Therapy Services Growth | -4.10% | 21.06% | 132.52% | 466.58% | - | | | | | |
| 6.40M | 4.61M | 26.19M | 24.48M | 19.55M | | | | | |
| 38.79% | -82.39% | 6.99% | 25.21% | -1.33% | | | | | |
| - | - | 6.09B | - | - | | | | | |
| 12.28B | 11.54B | 10.27B | 7.44B | 5.13B | | | | | |
| 6.39% | 12.39% | 37.92% | 45.00% | 36.64% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 2.27B | 1.84B | 1.48B | 1.16B | 979.76M | | | | | |
| 23.18% | 24.35% | 27.52% | 18.71% | - | | | | | |
| 7.85B | 7.40B | 6.64B | 4.78B | 3.27B | | | | | |
| 6.11% | 11.39% | 39.03% | 46.08% | - | | | | | |
| 39.51M | 48.87M | 25.01M | 33.96M | 39.31M | | | | | |
| -19.17% | 95.40% | -26.34% | -13.61% | - | | | | | |
| 1.85B | 1.97B | 1.88B | 1.27B | 700.22M | | | | | |
| -6.46% | 5.02% | 47.50% | 82.08% | - | | | | | |
Asia (Excluding Chinese Mainland) | 264.27M | 269.04M | 233.48M | 192.87M | 142.92M | | | | | |
Asia (Excluding Chinese Mainland) Growth | -1.77% | 15.23% | 21.05% | 34.95% | - | | | | | |
| 12.28B | 11.54B | 10.27B | 7.44B | 5.13B | | | | | |
| 6.39% | 12.39% | 37.92% | 45.00% | 36.64% | | | | | |
Source: S&P Global Market Intelligence.
